Cargando…

Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity

Clostridium difficile infection (CDI) is an important cause of mortality and morbidity in healthcare settings. The major virulence determinants are large clostridial toxins, toxin A (tcdA) and toxin B (tcdB), encoded within the pathogenicity locus (PaLoc). Isolates vary in pathogenicity from hypervi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dingle, Kate E., Griffiths, David, Didelot, Xavier, Evans, Jessica, Vaughan, Alison, Kachrimanidou, Melina, Stoesser, Nicole, Jolley, Keith A., Golubchik, Tanya, Harding, Rosalind M., Peto, Tim E., Fawley, Warren, Walker, A. Sarah, Wilcox, Mark, Crook, Derrick W.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098275/
https://www.ncbi.nlm.nih.gov/pubmed/21625511
http://dx.doi.org/10.1371/journal.pone.0019993
_version_ 1782203952448667648
author Dingle, Kate E.
Griffiths, David
Didelot, Xavier
Evans, Jessica
Vaughan, Alison
Kachrimanidou, Melina
Stoesser, Nicole
Jolley, Keith A.
Golubchik, Tanya
Harding, Rosalind M.
Peto, Tim E.
Fawley, Warren
Walker, A. Sarah
Wilcox, Mark
Crook, Derrick W.
author_facet Dingle, Kate E.
Griffiths, David
Didelot, Xavier
Evans, Jessica
Vaughan, Alison
Kachrimanidou, Melina
Stoesser, Nicole
Jolley, Keith A.
Golubchik, Tanya
Harding, Rosalind M.
Peto, Tim E.
Fawley, Warren
Walker, A. Sarah
Wilcox, Mark
Crook, Derrick W.
author_sort Dingle, Kate E.
collection PubMed
description Clostridium difficile infection (CDI) is an important cause of mortality and morbidity in healthcare settings. The major virulence determinants are large clostridial toxins, toxin A (tcdA) and toxin B (tcdB), encoded within the pathogenicity locus (PaLoc). Isolates vary in pathogenicity from hypervirulent PCR-ribotypes 027 and 078 with high mortality, to benign non-toxigenic strains carried asymptomatically. The relative pathogenicity of most toxigenic genotypes is still unclear, but may be influenced by PaLoc genetic variant. This is the largest study of C. difficile molecular epidemiology performed to date, in which a representative collection of recent isolates (n = 1290) from patients with CDI in Oxfordshire, UK, was genotyped by multilocus sequence typing. The population structure was described using NeighborNet and ClonalFrame. Sequence variation within toxin B (tcdB) and its negative regulator (tcdC), was mapped onto the population structure. The 69 Sequence Types (ST) showed evidence for homologous recombination with an effect on genetic diversification four times lower than mutation. Five previously recognised genetic groups or clades persisted, designated 1 to 5, each having a strikingly congruent association with tcdB and tcdC variants. Hypervirulent ST-11 (078) was the only member of clade 5, which was divergent from the other four clades within the MLST loci. However, it was closely related to the other clades within the tcdB and tcdC loci. ST-11 (078) may represent a divergent formerly non-toxigenic strain that acquired the PaLoc (at least) by genetic recombination. This study focused on human clinical isolates collected from a single geographic location, to achieve a uniquely high density of sampling. It sets a baseline of MLST data for future comparative studies investigating genotype virulence potential (using clinical severity data for these isolates), possible reservoirs of human CDI, and the evolutionary origins of hypervirulent strains.
format Text
id pubmed-3098275
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30982752011-05-27 Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity Dingle, Kate E. Griffiths, David Didelot, Xavier Evans, Jessica Vaughan, Alison Kachrimanidou, Melina Stoesser, Nicole Jolley, Keith A. Golubchik, Tanya Harding, Rosalind M. Peto, Tim E. Fawley, Warren Walker, A. Sarah Wilcox, Mark Crook, Derrick W. PLoS One Research Article Clostridium difficile infection (CDI) is an important cause of mortality and morbidity in healthcare settings. The major virulence determinants are large clostridial toxins, toxin A (tcdA) and toxin B (tcdB), encoded within the pathogenicity locus (PaLoc). Isolates vary in pathogenicity from hypervirulent PCR-ribotypes 027 and 078 with high mortality, to benign non-toxigenic strains carried asymptomatically. The relative pathogenicity of most toxigenic genotypes is still unclear, but may be influenced by PaLoc genetic variant. This is the largest study of C. difficile molecular epidemiology performed to date, in which a representative collection of recent isolates (n = 1290) from patients with CDI in Oxfordshire, UK, was genotyped by multilocus sequence typing. The population structure was described using NeighborNet and ClonalFrame. Sequence variation within toxin B (tcdB) and its negative regulator (tcdC), was mapped onto the population structure. The 69 Sequence Types (ST) showed evidence for homologous recombination with an effect on genetic diversification four times lower than mutation. Five previously recognised genetic groups or clades persisted, designated 1 to 5, each having a strikingly congruent association with tcdB and tcdC variants. Hypervirulent ST-11 (078) was the only member of clade 5, which was divergent from the other four clades within the MLST loci. However, it was closely related to the other clades within the tcdB and tcdC loci. ST-11 (078) may represent a divergent formerly non-toxigenic strain that acquired the PaLoc (at least) by genetic recombination. This study focused on human clinical isolates collected from a single geographic location, to achieve a uniquely high density of sampling. It sets a baseline of MLST data for future comparative studies investigating genotype virulence potential (using clinical severity data for these isolates), possible reservoirs of human CDI, and the evolutionary origins of hypervirulent strains. Public Library of Science 2011-05-19 /pmc/articles/PMC3098275/ /pubmed/21625511 http://dx.doi.org/10.1371/journal.pone.0019993 Text en Dingle et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Dingle, Kate E.
Griffiths, David
Didelot, Xavier
Evans, Jessica
Vaughan, Alison
Kachrimanidou, Melina
Stoesser, Nicole
Jolley, Keith A.
Golubchik, Tanya
Harding, Rosalind M.
Peto, Tim E.
Fawley, Warren
Walker, A. Sarah
Wilcox, Mark
Crook, Derrick W.
Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity
title Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity
title_full Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity
title_fullStr Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity
title_full_unstemmed Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity
title_short Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity
title_sort clinical clostridium difficile: clonality and pathogenicity locus diversity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098275/
https://www.ncbi.nlm.nih.gov/pubmed/21625511
http://dx.doi.org/10.1371/journal.pone.0019993
work_keys_str_mv AT dinglekatee clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT griffithsdavid clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT didelotxavier clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT evansjessica clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT vaughanalison clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT kachrimanidoumelina clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT stoessernicole clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT jolleykeitha clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT golubchiktanya clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT hardingrosalindm clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT petotime clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT fawleywarren clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT walkerasarah clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT wilcoxmark clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT crookderrickw clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity